Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Mantovani, Alessandro ^a   Pernigo, Matteo ^a   Bergamini, Corinna ^a   Bonapace, Stefano ^b   Lipari, Paola ^b   Pichiri, Isabella ^a   Bertolini, Lorenzo ^b   Valbusa, Filippo ^b   Barbieri, Enrico ^b   Zoppini, Giacomo ^a   Bonora, Enzo ^a   Targher, Giovanni ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OUTPATIENT; PREVALENCE; SEX DIFFERENCE; SEX RATIO; SMOKING; SYSTOLE; TRANSTHORACIC ECHOCARDIOGRAPHY; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DOPPLER ULTRASONOGRAPHY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; LIVER; METABOLISM; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; STATISTICAL MODEL;

AGED; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; LIVER; LOGISTIC MODELS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; ODDS RATIO; OVERWEIGHT; ULTRASONOGRAPHY, DOPPLER; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84942107494     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135329     Document Type: Article

References (42)

1. Targher G, Byrne CD. Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab 2013; 98:483-495. doi: 10.1210/jc.2012-3093 PMID: 23293330
2. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30:1212-1218. PMID: 17277038
3. Leite NC, Salles GF, Araujo AL, Villela-Nogueira CA, Cardoso CR. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Liver Int 2009; 29:113-119. doi: 10.1111/j.1478-3231.2008.01718.x PMID: 18384521
4. Leite NC, Villela-Nogueira CA, Pannain VL, Bottino AC, Rezende GF, Cardoso CR, et al. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. Liver Int 2011; 31:700-706. doi: 10.1111/j.1478-3231.2011.02482.x PMID: 21457442
5. Portillo-Sanchez P, Bril F, Maximos M, Lomonaco R, Biernacki D, Orsak B, et al. High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. J Clin Endocrinol Metab 2015; 100:2231-2238. doi: 10.1210/jc.2015-1966 PMID: 25885947
6. Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 2013; 10:330-344. doi: 10.1038/nrgastro.2013.41 PMID: 23507799
7. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363:1341-1350. doi: 10.1056/NEJMra0912063 PMID: 20879883
8. Armstrong MJ, Adams LA, Canbay A, Syn WK. Extra-hepatic complications of nonalcoholic fatty liver disease. Hepatology 2014; 59:1174-1197. doi: 10.1002/hep.26717 PMID: 24002776
9. Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20:1724-1745. doi: 10.3748/wjg.v20.i7.1724 PMID: 24587651
10. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004; 25:543-567. PMID: 15294881
11. Bonapace S, Perseghin G, Molon G, Canali G, Bertolini L, Zoppini G, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 2012; 35:389-395. doi: 10.2337/dc11-1820 PMID: 22210573
12. Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol 2006; 48:1548-1551. PMID: 17045886
13. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 2006; 354:2473-2483. PMID: 16760447
14. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54:1082-1090. doi: 10.1002/hep.24452 PMID: 21618575
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al; American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7:79-108. PMID: 16458610
16. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22:107-133. doi: 10.1016/j.echo.2008.11.023 PMID: 19187853
17. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30:1527-1533. PMID: 9362412
18. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 2000; 102:1788-1794. PMID: 11023933
19. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997; 30:474-480. PMID: 9247521
20. Rivas-Gotz C, Khoury DS, Manolios M, Rao L, Kopelen HA, Nagueh SF. Time interval between onset of mitral inflow and onset of early diastolic filling velocity by tissue Doppler: a novel index of left ventricular relaxation: experimental studies and clinical application. J Am Coll Cardiol 2003; 42:1463-1470. PMID: 14563593
21. Reisner SA, Lysyansky P, Agmon Y, Mutlak D, Lessick J, Friedman Z. Global longitudinal strain: a novel index of left ventricular systolic function. J Am Soc Echocardiogr 2004; 17:630-633. PMID: 15163933
22. Wang J, Khoury DS, Thohan V, Torre-Amione G, Nagueh SF. Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures. Circulation 2007; 115:1376-1383. PMID: 17339549
23. Bonapace S, Targher G, Molon G, Rossi A, Costa A, Zenari L, et al. Relationship between early diastolic dysfunction and abnormal microvolt T-wave alternans in patients with type 2 diabetes. Circ Cardiovasc Imaging 2011; 4:408-414. doi: 10.1161/CIRCIMAGING.110.962951 PMID: 21502332
24. Chapman CB, Ewer SM, Kelly AF, Jacobson KM, Leal MA, Rahko PS. Classification of left ventricular diastolic function using American Society of Echocardiography guidelines: agreement among echocardiographers. Echocardiography 2013; 30:1022-1031. doi: 10.1111/echo.12185 PMID: 23551740
25. Ratziu V, Caldwell S, Neuschwander-Tetri BA. Therapeutic trials in nonalcoholic steatohepatitis: insulin sensitizers and related methodological issues. Hepatology 2010; 52:2206-2215. doi: 10.1002/hep. 24042 PMID: 21105109
26. van der Meer RW, Rijzewijk LJ, de Jong HW, Lamb HJ, Lubberink M, Romijn JA, et al. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation 2009; 119:2069-2077. doi: 10.1161/CIRCULATIONAHA.108.803916 PMID: 19349323
27. Woo JS, Kim W, Ha SJ, Kim JB, Kim SJ, Kim WS, et al. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. Arterioscler Thromb Vasc Biol 2013; 33:2252-2260. doi: 10.1161/ATVBAHA.113.301586 PMID: 23868944
28. Targher G, Mantovani A, Pichiri I, Rigolon R, Dauriz M, Zoppini G, et al. Nonalcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. Clin Sci (Lond) 2013; 125:301-309.
29. Targher G, Valbusa F, Bonapace S, Bertolini L, Zenari L, Rodella S, et al. Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. PLoS One 2013; 8:e57183. doi: 10.1371/journal.pone.0057183 PMID: 23451184
30. Andersen MJ, Ersbøll M, Bro-Jeppesen J, Gustafsson F, Hassager C, Køber L, et al. Exercise hemodynamics in patients with and without diastolic dysfunction and preserved ejection fraction after myocardial infarction. Circ Heart Fail 2012; 5:444-451. doi: 10.1161/CIRCHEARTFAILURE.112.967919 PMID: 22705767
31. Goland S, Shimoni S, Zornitzki T, Knobler H, Azoulai O, Lutaty G, et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J Clin Gastroenterol 2006; 40:949-955. PMID: 17063117
32. Hallsworth K, Hollingsworth KG, Thoma C, Jakovljevic D, MacGowan GA, Anstee QM, et al. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. J Hepatol 2013; 58:757-762. doi: 10.1016/j.jhep.2012.11.015 PMID: 23178979
33. Alp H, Karaarslan S, Selver Eklioglu B, Atabek ME, Altin H, Baysal T. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents. Can J Cardiol 2013; 29:1118-1125. doi: 10.1016/j.cjca.2012.07.846 PMID: 23040432
34. Singh GK, Vitola BE, Holland MR, Sekarski T, Patterson BW, Magkos F, et al. Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. J Pediatr 2013; 162:1160-1168. doi: 10.1016/j.jpeds.2012.11.024 PMID: 23260104
35. Sert A, Aypar E, Pirgon O, Yilmaz H, Odabas D, Tolu I. Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease. Am J Cardiol 2013; 112:436-443. doi: 10.1016/j.amjcard.2013.03.056 PMID: 23642511
36. Pacifico L, Di Martino M, De Merulis A, Bezzi M, Osborn JF, Catalano C, et al. Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease. Hepatology 2014; 59:461-470. doi: 10.1002/hep.26610 PMID: 23843206
37. Petta S, Argano C, Colomba D, Cammà C, Di Marco V, Cabibi D, et al. Epicardial fat, cardiac geometry and cardiac function in patients with nonalcoholic fatty liver disease: association with the severity of liver disease. J Hepatol 2015; 62:928-933. doi: 10.1016/j.jhep.2014.11.030 PMID: 25445395
38. Lim S, Meigs JB. Ectopic fat and cardiometabolic and vascular risk. Int J Cardiol 2013; 169:166-176. doi: 10.1016/j.ijcard.2013.08.077 PMID: 24063931
39. Byrne CD, Targher G. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. Arterioscler Thromb Vasc Biol 2014; 34:1155-1161. doi: 10.1161/ATVBAHA.114.303034 PMID: 24743428
40. Rijzewijk LJ, Jonker JT, van der Meer RW, Lubberink M, de Jong HW, Romijn JA, et al. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes. J Am Coll Cardiol 2010; 56:225-233. doi: 10.1016/j.jacc.2010.02.049 PMID: 20620743
41. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008; 52:1793-1799. doi: 10.1016/j.jacc.2008.07.062 PMID: 19022158
42. Granér M, Nyman K, Siren R, Pentikäinen MO, Lundbom J, Hakkarainen A, et al. Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease. Circ Cardiovasc Imaging 2015; 8:e001979. doi: 10.1161/CIRCIMAGING.114.001979 PMID: 25550397